Spring, I agree with your perspectives.

All we here and see from RVX is continued excellent results and new understandings including the first dosing of the BETonMACE trial.

1. I think we are in a Catch 22.
2. RVX doesn't have a NASDAQ listing. Therefore there is little credibility for the stock amoung US investors.
3. As a result us RVX shareholders don't benefit from the stength of a much larger market in which there are thousands more risk takers.
4. The TSX is very limited in terms of breadth with progressive investors.
5. Ledenfrog tells us that there are some types of investors out there that are manipulating the price down.
6. In order to get a NASDAQ listing we need the stock above $3.00 for a number of weeks from what I understand.

So, frankly I think we are stuck. However, we saw that what was possibly insider information regarding the Hepalink deal drove the stock up $3.13. So who knows if new licensing deals or science will drive the stock up to the level of a NASDAQ listing.

Probably good to just sit back for a few years, let it go where it goes and then cash in for a blockbsuter!!!.

Cheers

Toinv